The controversial sponsorship deal between Sanofi-Aventis and the Baker IDI Heart and Diabetes Institute has been found to be in breach of the Medicines Australia code of conduct.
Under the deal, for every Plavix script dispensed through retail pharmacy in 2009, Sanofi-Aventis agreed to donate 25 cents to support the Baker’s medical research and preventative health [...]
-
Pages
-
Categories
- adverse events
- alcohol
- Australian Medical Association
- cancer
- child health
- childbirth and maternity services
- chronic diseases
- climate change
- Cochrane Collaboration
- complementary medicines
- conflicts of interest
- consumer health information
- Crikey register of influence
- Croakey Register of Unreleased Documents
- dental care
- e-health
- education
- environmental health
- evidence-based issues
- Federal Budget 2009-2010
- Food
- general practice
- global health
- health & medical marketing
- health and medical education
- health and medical research
- health ethics
- health financing and costs
- Health inequalities
- health reform
- health regulation
- health workforce
- Hospitals
- HRT
- illicit drugs
- Indigenous education
- Indigenous health
- infectious diseases
- influenza
- international medical graduates
- Journal articles
- legal issues
- Media-related issues
- medical education
- men's health
- mental health
- NHMRC
- NT Intervention
- nurses and nursing
- obesity
- pathology
- pharmaceutical industry
- pharmacy
- physical activity
- poverty
- prevention
- primary health care
- private health insurance
- public health
- quality and safety of health care
- rural and remote health
- screening
- surgery
- swine flu
- tests
- TGA
- tobacco control
- trauma
- Uncategorized
- weight loss products
-
Archives
